TrialThe New England journal of medicine2021
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
Aditya Bardia et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
980 papers cite itlatest 60 shown
this paperpooled ittrialcites it